Search Results to David P. Nunes, MD, FRCPI

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Nunes, David

Research Expertise & Professional Interests Expertise includes: Clinical liver disease - interest in viral hepatitis; Evaluation and management of liver lesions.
Self-Described Keywords Hepatitis B
Self-Described Keywords Hepatitis C

One or more keywords matched the following items that are connected to Nunes, David

Item TypeName
Concept Hepatitis B Antibodies
Concept Hepatitis B Surface Antigens
Concept Hepatitis B Vaccines
Concept Hepatitis C, Chronic
Academic Article An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C.
Academic Article Managing hepatitis C infection in HIV-positive patients.
Academic Article Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
Academic Article Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection.
Academic Article Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.
Academic Article Another step forward: treating HCV infection in HIV coinfected patients.
Academic Article Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care.
Academic Article HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.
Academic Article Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.
Academic Article Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problems.
Academic Article Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection.
Academic Article Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems.
Academic Article Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.
Academic Article Impact of hepatitis C on HIV progression in adults with alcohol problems.
Academic Article Awareness of hepatitis C diagnosis is associated with less alcohol use among persons co-infected with HIV.
Academic Article Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C.
Academic Article Predictors of treatment for hepatitis C virus (HCV) infection in drug users.
Academic Article Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.
Academic Article Synergetic chemiluminescence and label-free dual detection for developing a hepatitis protein array.
Academic Article Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.
Academic Article Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection.
Academic Article Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems.
Academic Article Antiretroviral rounds. A co-infection treatment dilemma.
Academic Article CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users.
Academic Article Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men.
Grant A Prospective, Randomized, Multicenter, Open Label Comparative Safety Study of Pegasys vs. Pegasys Plus Ribavirin Treatment vs. a Twelve Treatment Delay in Patients with Chronic Hepatitis C
Grant Phase II Study Of Long Term Peg Intron Fpr Patients Who Have Failed to Respond to Rebetron/Interferon with Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C.
Grant A Randomized, Placebo Controlled, Phase 1b Trial to Evaluate the Safety and Pharmacokinetics of NOV-205 in Chronic Viral Hepatitis C Subjects (Genotype 1) who have failed Treatment with Pegylated Interferon plus Ribavirin
Grant Comparison of PEG Interferon Alfa 2b Plus Ribavirin Given as a Fixed Dose or on a Weight Optimized Basis for Treatment of Chronic Hepatitis C in Previously Untreated Adult Subjects
Grant A Randomized, Partially Blinded, Multicenter, Phase II Study Investigating the Efficacy and Safety of Pegasys and Pegasys with Ribavirin in Treatment Naive Patients with Chronic Hepatitis C Coinfected with Human Immunodeficiency Virus
Grant A Study to Describe the Safety and Antiviral Effect of Entecavir (ETV) in Blacks/African Americans and Hispanics with Chronic Hepatitis B Virus (HBV) Infection who are Nucleoside-Naive
Academic Article Hepatitis C virus infection in kidney transplantation-changing paradigms with novel agents.
Academic Article Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital.
Academic Article Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy.
Academic Article Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease.

Search Criteria
  • Hepatitis C